カテゴリ： MarketLine, アメリカ, 企業調査

Alleghany Corporation：企業の戦略・SWOT・財務情報

◆英語タイトル：Alleghany Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3984
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥22,750見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥45,500見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥68,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Alleghany Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Alleghany Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Alleghany Corporation (Alleghany) is a property and casualty reinsurance and insurance company. The company, through its subsidiaries, offers property and casualty reinsurance for various lines of businesses including accident and health, aviation and marine, engineering, agriculture, energy, surety, mortgage indemnity, medical liability and entertainment. It also offers property and casualty insurance products for healthcare, construction, transportation, manufacturing, professional liability, and mid-size commercial businesses. It also offers surety and fidelity bonds, and workers’ compensation insurance. Alleghany offers its products and services directly and through independent wholesale brokers and retail agents across the Americas, Europe, Asia-Pacific, and Africa. Alleghany is headquartered in New York City, New York.

The company reported gross premiums written of US$5,696.9 million during fiscal year ended December 2017 (FY2017), a decline of 1.2% over FY2016. Its net premium written was US$4,965.9 million in FY2017, a decline of 2.5% over FY2016.

Scope

- Detailed information on Alleghany Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Alleghany Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Alleghany Corporation including a breakdown and examination of key business segments
- Intelligence on Alleghany Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Alleghany Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Alleghany Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Alleghany Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Alleghany Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Alleghany Corporation: Company Overview 9
Alleghany Corporation: Overview and Key Facts 9
Alleghany Corporation: Overview 9
Alleghany Corporation: Key Facts 9
Alleghany Corporation: Key Employees 11
Alleghany Corporation: Key Employee Biographies 12
Alleghany Corporation: Major Products and Services 14
Alleghany Corporation: Company History 15
Alleghany Corporation: Management Statement 17
Alleghany Corporation: Locations and Subsidiaries 20
Alleghany Corporation: Key Competitors 21
Alleghany Corporation: Company Analysis 22
Alleghany Corporation: Business Description 22
Alleghany Corporation: SWOT Analysis 23
Alleghany Corporation: SWOT Overview 23
Alleghany Corporation: Strengths 23
Alleghany Corporation: Weaknesses 24
Alleghany Corporation: Opportunities 24
Alleghany Corporation: Threats 25
Alleghany Corporation: Corporate Financial Deals Activity 26
Alleghany Corporation: Financial Deals Overview 26
Alleghany Corporation: Targets and Partners 28
Alleghany Corporation: Top Deals 2014 – 2018YTD* 29
Alleghany Corporation: Advisors 30
Alleghany Corporation: Top Legal Advisors 30
Alleghany Corporation: Top Financial Advisors 30
Alleghany Corporation: Corporate Venturing 31
Alleghany Corporation: Partnership 32
Alleghany Corporation: Divestments 33
Alleghany Corporation: Recent Developments 34
Alleghany Corporation: News and Events Summary 34
Alleghany Corporation: Business Expansion 36
Alleghany Corporation: Contracts 36
Alleghany Corporation: Corporate Governance 38
Alleghany Corporation: Financial Performance 39
Alleghany Corporation: Strategy and Operations 39
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42

List of Tables
Table 1: Alleghany Corporation: Key Facts
Table 2: Alleghany Corporation: Key Employees
Table 3: Alleghany Corporation: Locations and Subsidiaries
Table 4: Alleghany Corporation: Key Competitors
Table 5: Alleghany Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Alleghany Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Alleghany Corporation: Targets and Partners
Table 8: Alleghany Corporation: Top Deals 2014 - 2018YTD*
Table 9: Alleghany Corporation: Legal Advisor Ranking by Value (US$m)
Table 10: Alleghany Corporation: Financial Advisor Ranking by Value (US$m)
Table 11: Alleghany Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Alleghany Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Alleghany Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Alleghany Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Alleghany Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Alleghany Corporation: Divestments by Geography (2014 - YTD*2018)
Table 17: Alleghany Corporation: News and Events Summary
Table 18: Alleghany Corporation: Business Expansion
Table 19: Alleghany Corporation: Contracts
Table 20: Alleghany Corporation: Corporate Governance
Table 21: Alleghany Corporation: Financial Performance
Table 22: Alleghany Corporation: Strategy and Operations

List of Figures
Figure 1: Alleghany Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Alleghany Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Alleghany Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 4: Alleghany Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 5: Alleghany Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Alleghany Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 7: Alleghany Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 8: Alleghany Corporation: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Alleghany Corporation：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • BelAZ：企業の戦略・SWOT・財務分析
    BelAZ - Strategy, SWOT and Corporate Finance Report Summary BelAZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Aurora Spine Corp (ASG)：企業の財務・戦略的SWOT分析
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • DexTech Medical AB：製薬・医療：M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Sangoma Technologies Corporation (STC)：企業の財務・戦略的SWOT分析
    Sangoma Technologies Corporation (STC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Xero Ltd (XRO)：企業の財務・戦略的SWOT分析
    Xero Ltd (XRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Helijet International Inc.：企業の戦略・SWOT・財務情報
    Helijet International Inc. - Strategy, SWOT and Corporate Finance Report Summary Helijet International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野：企業M&A・提携分析
    Summary Fujifilm Diosynth Biotechnologies USA Inc (Fujifilm Diosynth), a subsidiary of Fujifilm Corp, is a contract development and manufacturing organization that develops therapeutic products, biologics and vaccines. The organization also develops processes for molecules expressed through fermenta …
  • Tanabe Research Laboratories USA Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Tanabe Research Laboratories USA Inc (Tanabe Research Laboratories USA), a subsidiary of Mitsubishi Tanabe Pharma Corp is a healthcare research center that discovers and develops biological drugs. The laboratory conducts research on metabolics, immunology and inflammation. Its products are u …
  • Dynasil Corporation of America (DYSL)：企業の財務・戦略的SWOT分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company’s products include beam splitters, bandpass filters, coatings, crystal materials, imaging detectors, diffraction gratings, tunable light sourc …
  • Clean Harbors, Inc. (CLH)：企業の財務・戦略的SWOT分析
    Clean Harbors, Inc. (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • B&M European Value Retail S.A.：戦略・SWOT・企業財務分析
    B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report Summary B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Astellas Pharma US Inc-製薬・医療分野：企業M&A・提携分析
    Summary Astellas Pharma US Inc (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a drug company that offers injections and tablets. The company offers products such as adenosine injections, regadenoson injection, tacrolimus ointment, tacrolimus extended-release capsules, tacrolimus capsules …
  • Bovie Medical Corp (BVX)-医療機器分野：企業M&A・提携分析
    Summary Bovie Medical Corp (Bovie Medical) is a manufacturer of medical devices and supplies. The company offers J-plasma, electrosurgery, veterinary products, acudop ii dopplers, clearspec speculum, colposcopes, cryosurgery, dermascout dermatoscope, medical lights, nerve locators, ophthalmic produc …
  • Protokinetix Inc (PKTX)：企業の財務・戦略的SWOT分析
    Summary ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and k …
  • Tobira Therapeutics Inc (TBRA)-医療機器分野：企業M&A・提携分析
    Summary Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Ev …
  • Lantronix, Inc. (LTRX)：企業の財務・戦略的SWOT分析
    Lantronix, Inc. (LTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Castrol India Ltd (CASTROLIND)：企業の財務・戦略的SWOT分析
    Summary Castrol India Ltd (Castrol India), a subsidiary of Castrol Limited, is an oil and gas company that manufactures, distributes and markets lubricant products. The company provides products such as lubricants, premium lubricating oils and greases, antifreeze and coolant, greases, engine oils, d …
  • Save The Children Federation Inc：企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Second Sight Medical Products Inc (EYES)：企業の財務・戦略的SWOT分析
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • Recepta Biopharma SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Recepta Biopharma SA (Recepta) is a biotechnology company that offers research and development of drugs used in the treatment of cancer. The company offers antibodies and peptide products. It offers antibodies such as monoclonal antibody hu3s193 - anti-ley, monoclonal antibody 58-1066 - anti …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆